Dr Reddys Laboratories (RDY) Revenue (QoQ) (2009 - 2023)
Dr Reddys Laboratories (RDY) Revenue (QoQ) (2009 - 2023) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 2.10% |
| Mar 31, 2023 | 5.74% |
| Dec 31, 2022 | -100.00% |
| Jun 30, 2021 | 17.19% |
| Sep 30, 2020 | 0.60% |
| Jun 30, 2020 | 11.65% |
| Sep 30, 2019 | -8.77% |
| Jun 30, 2019 | 23.71% |
| Mar 31, 2019 | -6.37% |
| Dec 31, 2018 | 4.31% |
| Sep 30, 2018 | 6.30% |
| Jun 30, 2018 | 2.14% |
| Mar 31, 2018 | -0.58% |
| Dec 31, 2017 | -11.79% |
| Dec 31, 2016 | -0.86% |
| Mar 31, 2016 | -4.62% |
| Dec 31, 2015 | -2.50% |
| Sep 30, 2015 | -1.64% |
| Dec 31, 2014 | 1.80% |
| Mar 31, 2014 | 1.03% |